146 related articles for article (PubMed ID: 1472262)
1. Effect of losartan potassium and deoxycorticosterone acetate on tail skin temperature response to acute administration of angiotensin II.
Fregly MJ; Rowland NE
Pharmacol Biochem Behav; 1992 Sep; 43(1):229-33. PubMed ID: 1472262
[TBL] [Abstract][Full Text] [Related]
2. Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.
Fregly MJ; Rowland NE
Brain Res Bull; 1991 Jul; 27(1):97-100. PubMed ID: 1933441
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
Eberhardt RT; Kevak RM; Kang PM; Frishman WH
J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
[TBL] [Abstract][Full Text] [Related]
4. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting angiotensin II-induced hypothermia in rats.
Wilson KM; Fregly MJ
Peptides; 1985; 6(4):695-701. PubMed ID: 4070024
[TBL] [Abstract][Full Text] [Related]
6. Tonic neuronal inhibition by AII revealed by iontophoretic application of Losartan, a specific antagonist of AII type-1 receptors.
Martial FP; Thornton SN; Lienard F; Mousseau MC; Nicolaidis S
Brain Res Bull; 1994; 34(6):533-9. PubMed ID: 7922595
[TBL] [Abstract][Full Text] [Related]
7. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
8. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
9. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
Chiu AT; Roscoe WA; McCall DE; Timmermans PB
Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
[TBL] [Abstract][Full Text] [Related]
11. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats.
Fregly MJ; Rowland NE
Proc Soc Exp Biol Med; 1992 Feb; 199(2):158-64. PubMed ID: 1311103
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
Robberecht W; Andries M; Denef C
Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin II and AT1 receptors in hippocampal LTP.
Wayner MJ; Armstrong DL; Polan-Curtain JL; Denny JB
Pharmacol Biochem Behav; 1993 Jun; 45(2):455-64. PubMed ID: 8327552
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN
J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
18. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
[TBL] [Abstract][Full Text] [Related]
19. Effect of various angiotensin receptor antagonists on cardiovascular responses to angiotensin II in pithed rats.
Zhang J; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1994 Jul; 24(1):108-13. PubMed ID: 7521474
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
